Institutions Have Been Holding Back, but Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Beginning to Stabilize
Teva Pharmaceutical Industries Ltd. stock (NYSE: TEVA) suffers the loss of exclusivity on key drugs - Best Stocks
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva Pharmaceuticals on Twitter: "Charlene Brisbane, Senior Director of Biologics CMC, Drug Product Development & Operations at Teva shares how mentoring helped shape her professional journey. #PharmaCareers Read her story: https://t.co/YCgETITF9T ...
Teva shares plunge gain after weak third-quarter earnings - The Jerusalem Post
Here's why Teva shares are trending higher today - gerona
Teva Shares Hit by Opioid Fallout - Hamodia.com
Teva Pharmaceutical Industries Ltd. – Artonpapers
Teva shares surge after announcing global opioid settlement
Berkshire Hathaway exits Teva at a loss - גלובס
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Must Clear Three Big Hurdles to Reclaim Its Perch - TheStreet
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva Shares Slump on Opioid Litigation Risk Downgrade From Morgan Stanley - TheStreet
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel